Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

FDA Pushing for Limits on Antibiotics in Meat

By Drug Discovery Trends Editor | June 29, 2010

WASHINGTON (AP) – The Food and Drug Administration is urging meat producers to limit the amount of antibiotics they give animals in response to public health concerns about the drugs.

The FDA said antibiotics in meat pose a “serious public health threat” because the drugs create antibiotic-resistant bacteria that can infect humans who eat it. The agency is recommending that producers use the drugs judiciously, limiting their use unless they are medically necessary and only using them with the oversight of a veterinarian.

“Developing strategies for reducing (antibiotic) resistance is critically important for protecting both public and animal health,” the agency said in draft guidelines printed in the Federal Register on Monday.

The agency said misuse and overuse of the drugs has led to the development of antibiotic-resistant bacteria. Antibiotics have been given to animals to kill pathogens for more than 50 years, and the FDA acknowledged that practice has had “tremendous benefits” to animal and human health.

Of greater concern, the agency said, is when producers use antibiotics on healthy animals to speed growth and reduce feed costs. The agency is also concerned about antibiotics that are given continuously through feed or water to entire herds or flocks of animals.

The agency said it is expecting to issue more specific guidelines soon, but FDA Principal Deputy Commissioner of Food and Drugs Joshua Sharfstein would not say whether the agency eventually plans to issue stricter regulations. He said the guidelines are just a first step and the agency will be watching industry response and also patterns of antibiotic resistance.

Advocates on both sides of the issue criticized the decision.

Sam Carney, a pork producer from Adair, Iowa, and president of the National Pork Producers Council, said reducing the amount of antibiotics given to animals could harm their health.

“As we know, healthy animals produce safe food, and we need every available tool to protect animal health,” he said.

But Steven Roach, a public health advocate with the group Keep Antibiotics Working, a coalition dedicated to eliminating the overuse of antibiotics, said the guidelines don’t go far enough.

“It shows the FDA still has no plan to take the necessary steps to protect public health by stopping the non-therapeutic use of antibiotics in animal agriculture,” he said.

Date: June 28, 2010
Source: Associated Press


Filed Under: Drug Discovery

 

Related Articles Read More >

The FDA’s AI ambitions depend on better data practices
Researchers working in the clinical laboratory
Outpatient clinics are becoming critical Infrastructure for drug trials
SAS launches clinical trial analytics software built on its Viya cloud native analytics platform
Bayer’s Lynkuet approved by FDA for menopausal hot flashes
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE